Welcome Guest
| Login
Book Details
|
|
Psychiatry (2ND)
Publisher :
Oxford Univ Pr
Published Date : 2010/04
Binding : Paperback
ISBN : 9780195372748
BookWeb Price : AED 211.00 Availability Status : Our fulfillment centre has the item in stock. Usually dispatches within 3 working days. Language : English |
| Stock Information | |||
|---|---|---|---|
| Store | Shelf Location | Click here | Stock |
| Dubai | D03-01, B21-02, B22-04 | Map |
|
|
|
Important |
|
Book Description
Source: ENG
Academic Descriptors: A67010000
Place of Publication: United States
Edition: Subsequent
Textual Format: Textbooks,Lower Level
Academic Level: Graduate
Academic Descriptors: A67010000
Place of Publication: United States
Edition: Subsequent
Textual Format: Textbooks,Lower Level
Academic Level: Graduate
Table of Contents
CONTRIBUTORS xxv
1. PSYCHIATRIC ASSESSMENT AND TREATMENT PLANNING 1
Janis L. Cutler
Chief Complaint 2
History 3
History of the Present Illness 3
Past Psychiatric History 6
Past Medical History 6
Review of Systems 6
Psychosocial History 7
Family History 8
Mental Status Examination 8
Other Findings 10
Physical Examination 10
Laboratory Tests 18
Impressions 18
Case Summary 18
Differential Diagnosis 19
Multiaxial Evaluation 19
Predisposing and Precipitating Factors 21
Treatment Plan 21
Prognosis 21
2. THE PSYCHIATRIC INTERVIEW 23
Lyle Rosnick
Interview Models 23
The Medical Model 23
The Psychodynamic Model 24
Object Relations Theory 24
Ego Psychology 26
Psychosexual Development 26
Defense Mechanisms 27
Transference and Resistance 29
Conducting the Interview 29
Scheduling the Interview 30
The Interview Setting 30
Safety 30
Language 30
Beginning the Interview 31
Chief Complaint and History of the 32
Present Illness
Past Psychiatric History 33
Past Medical History 33
Review of Major Realms of Psychopathology 34
General Screening Questions 34
Mood Disorders 35
Depression and Dysthymia 35
Mania and Hypomania 36
Suicide 37
Anxiety Disorders 37
Generalized Anxiety 37
Panic Attack or Disorder 37
Obsessive-Compulsive Disorder 38
Phobias 38
Substance-related Disorders 38
Cognitive Disorders 39
Psychosis 40
Eating Disorders 40
Personality and Personality Disorders 41
Psychosocial History 42
Family History 46
Mental Status Examination 46
Sample Interviews 46
Interview One 46
Interview Two 48
Interview Three 49
Discussion 50
Concluding the Interview 50
3. MOOD DISORDERS 53
Leo Sher, David A. Kahn, and Maria A. Oquendo
Diagnostic and Clinical Features 53
Major Depression 55
Psychological Symptoms and Signs 55
Behavioral Symptoms and Signs 57
Subtypes 59
Suicidal Thoughts and Behaviors 61
Dysthymic Disorder 61
Bipolar Disorder 61
Mania 64
Mania with Psychosis 67
Rapid-cycling Subtype 67
Mixed States 68
Hypomania 68
Cyclothymia 69
Geriatric Issues 69
Catatonia 70
Epidemiology and Course of Illness 70
Major Depression 72
Bipolar Disorder 73
The Interview 74
Depressive Disorders 74
Bipolar Disorder 76
Differential Diagnosis 79
Medical Evaluation 82
Etiology 83
Neurobiological Theories 83
Neurotransmitter Hypotheses 83
Neuroendoaine Hypotheses 84
Chronobiological Theories 85
Sensitization and Kindling Theory 85
Genetic Factors 86
Psychosocial Theories 87
Psychoanalytic Theory 87
Interpersonal Theory 88
Cognitive Theory 89
Treatment 89
Pharmacotherapy 90
Antidepressant Agents 90
Adjunctive Drugs 91
Treatment of Bipolar Depression 91
Lithium and Other Mood-stabilizing Drugs 92
Preventive Pharmacotherapy 93
Electroconvulsive Therapy 94
Psychotherapy 94
Cognitive Therapy 94
Interpersonal Psychotherapy 95
Psychodynamic Psychotherapy 96
Long-term Psychotherapy and Preventive 96
Treatment
Psychotherapy in Combination with 96
Pharmacotherapy
Bipolar Disorder 98
4. SC.HIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS 101
Thomas Smith, Ewald Horvath, and Francine
Cournos
Diagnostic and Clinical Features 101
Symptoms of Schizophrenia 103
Positive Symptoms 103
Negative Symptoms 106
Disorganized Symptoms 107
Subtypes of Schizophrenia 108
Other Psychotic Disorders 108
Schizophreniform Disorder 108
Schizoaffedive Disorder 109
Delusional Disorder 109
Brief Psychotic Disorder 109
Psychotic Disorder Due to a General 109
Medical Condition
Substance-induced Psychotic Disorder 110
Course of Illness 110
The Interview 112
Differential Diagnosis 114
Medical Evaluation 116
Etiology 117
Neurobiology 117
Genetic Factors 117
Neurochemical Factors 118
Neurodevelopmental Factors 119
Seasonal Birth Patterns 120
Psychosocial Factors 120
Treatment 120
Pharmacotherapy 121
First-generation Antipsychotic 121
Medications
Second-generation Antipsychotic 121
Medications
Side Effects of Antipsychotic 122
Medications
Pharmacotherapy for Acute Episodes 124
Pharmacotherapy for Other Psychotic 125
Disorders
Treatment Adherence 125
Treatment of Prodromal Schizophrenia 125
Psychosocial Treatment 126
Individual Psychotherapy 126
Group Therapy 127
Family Therapy 127
Psychoeducation 127
Peer Support and Self-help Groups 127
Vocational Support Programs 127
Therapeutic Settings 128
Institutional and Residential Care 128
Hospital Treatment 128
Community Residences 129
Day Programs and Rehabilitative Programs 129
Psychosocial Clubs 129
Assertive Community Treatment 129
Crisis Intervention, Emergency Services, 130
Outreach Services, Case Management, and
Commitment
Barriers to the Care of People with 130
Schizophrenia
Stigma 130
Substance Use Comorbidity 130
Jails and Prisons 131
5. COGNITIVE DISORDERS AND MENTAL DISORDERS DUE 132
TO GENERAL MEDICAL CONDITIONS
Jennifer M. Rucci and Robert E. Feinstein
Diagnostic and Clinical Features 132
Cognitive Disorders 132
Delirium 132
Course 135
Dementia 136
Course 137
Amnestic Disorder 138
Course 139
Mental Disorders Due to a General Medical 139
Condition
Psychotic Disorders Due to a General 139
Medical Condition
Mood Disorders Due to a General Medical 140
Condition
Anxiety Disorders Due to a General 140
Medical Condition
Personality Change Due to a General 141
Medical Condition
Course 142
The Interview 142
Interview Setting 143
Interview Questions 143
Therapeutic Interventions 144
Family Interview 144
Differential Diagnosis 145
Special Areas of Concern in Differential 147
Diagnosis
Medical Evaluation 149
Neurological Review of Systems 149
Physical Examination 149
Neurological Examination 150
Laboratory Tests 150
Neuroimaging 150
Electroencephalogram 150
Sleep Studies 151
Mental Status Testing and Neurobehavioral 151
Assessment
Etiology 157
Cognitive Disorders 157
Delirium 157
Dementia 157
Alzheimer Disease 157
Vascular Dementia 158
Parkinson Disease and Lewy Body Dementia 158
Frontal Temporal Dementia 158
Human Immunodeficiency Virus Infection 158
Huntington Disease 159
Normal Pressure Hydrocephalus 159
Cradzfeldt-Jakob Disease 159
Amnestic Disorder 159
Mental Disorders Due to a General Medical 159
Condition
Psychotic Disorders Due to a General 159
Medical Condition
Mood Disorders Due to a General Medical 160
Condition
Anxiety Disorders Due to a General 161
Medical Condition
Personality Changes Due to a General 162
Medical Condition
Treatment 162
Psychotherapy 162
Behavior Therapy 162
Operant-behavioral Treatment 163
Social Learning 163
Cognitive Behavior Therapy 163
Family Therapy 163
Psychoeducation 163
Structural Family Therapy 164
Strategic Family Therapy 165
Pharmacotherapy 166
Cognitive Enhancers 166
Antidepressants 166
Antipsychotics 167
Anxiolytics 167
Lithium 167
Anticonvulsants 168
Preventive Measures 168
6. ANXIETY DISORDERS 170
Franklin R. Schneier, Hilary B. Vidair,
Leslie It Vogel, and Philip R. Muskin
Diagnostic and Clinical Features 171
Panic Disorder 171
Agoraphobia 173
Social Phobia (Social Anxiety Disorder) 174
Specific Phobia 176
Obsessive-Compulsive Disorder 176
Posttraumatic Stress Disorder 178
Acute Stress Disorder 181
Generalized Anxiety Disorder 182
Anxiety Disorder Due to a General Medical 184
Condition
Substance-induced Anxiety Disorder 185
Stimulant Intoxication 185
Alcohol Withdrawal 186
Withdrawal from Other Central Nervous 186
System Depressants
Withdrawal from Opioids 187
Paradoxic Reactions 187
The Interview 188
Differential Diagnosis 190
Generalized Anxiety Disorder 190
Panic Disorder 191
Social Phobia 191
Specific Phobia 191
Obsessive-Compulsive Disorder 191
Posttraumatic Stress Disorder 192
Acute Stress Disorder 192
Medical Evaluation 194
Etiological Issues across Anxiety Disorders 195
Neurobiological Concepts 195
Genetic Predisposition and Interactions 195
with Environment
Neurotransmitters 196
The Hypothalamic鳳ituitary泡drenal Axis 198
Neurocircuitry, Attention, and Learning 198
Psychosocial Concepts 199
Cognitive Behavioral Approach 199
Psychoanalytic Approach 200
Treatment 200
General Principles of Pharmacotherapy 200
General Principles of Psychotherapy 201
Cognitive Behavior Therapy 201
Psychodynamic Psychotherapy 203
Etiology and Treatment of Specific 203
Anxiety Disorders
Panic Disorder and Agoraphobia 203
Etiology 203
Pharmacotherapy 204
Cognitive Behavior Therapy 204
Social Phobia (Social Anxiety Disorder) 204
Etiology 204
Pharmacotherapy 205
Cognitive Behavior Therapy 205
Obsessive-Compulsive Disorder 205
Etiology 205
Pharmacotherapy 205
Cognitive Behavior Therapy 206
Posttraumatic Stress Disorder 206
Etiology 206
Pharmacotherapy 206
Cognitive Behavior Therapy 206
Generalized Anxiety Disorder 207
Etiology 207
Pharmacotherapy 207
Cognitive Behavior Therapy 207
Specific Phobias 207
Etiology 207
Pharmacotherapy 207
Cognitive Behavior Therapy 207
Substance-induced Anxiety Disorder 208
Etiology 208
7. ALCOHOL AND SUBSTANCE USE DISORDERS 210
Benjamin R. Bryan and Frances R. Levin
Diagnostic and Clinical Features 210
Substance Use Disorders 213
Substance Abuse 213
Substance Dependence 213
Substance-Induced Disorders 214
Alcohol and Other Sedatives 215
Nicotine 220
Cannabis 220
Stimulants 222
Opioids 223
Hallucinogens 223
Anabolic-androgenic Steroids 226
Inhalants 227
Course of Illness 227
Alcohol 227
Recreational Drugs 228
The Interview 230
Substance Use History 230
Screening Tests 230
Family, Social, and Legal Histories 232
History Timeline 232
Assessment of Patient Reliability 233
Patient Engagement 234
Special Considerations in Children and 235
Adolescents
Special Considerations in the Elderly 236
Differential Diagnosis 239
Medical Evaluation 240
Laboratory Tests for Alcohol-related 242
Disorders
Laboratory Tests for Drug-related 243
Disorders
Etiology 245
Neurobiological Factors 245
Genetic Factors 245
Neurotransmitter Factors 246
Neuroendocrine Factors 246
Psychological Factors 246
Social Factors 247
Treatment 248
Recovery from Substance-related Disorders 248
Therapeutic Settings 250
Inpatient and Residential Chemical 251
Dependence Programs
Outpatient Programs 253
Residential Therapeutic Community 253
Programs
Psychotherapy 254
Pharmacotherapy 255
Dependence on Alcohol and Other 255
Sedatives
Detoxification from Alcohol and Other 256
Sedatives
Opioid Dependence 256
Opioid Detoxification 259
Cocaine Dependence 259
Cannabis Dependence 259
Nicotine Dependence 259
8. PERSONALITY DISORDERS 264
Eve Caligor, Frank Yeomans, and Ze'ev Levin
Personality and Personality Pathology 265
Diagnostic and Clinical Features 266
Cluster A: The Odd or Eccentric Cluster 268
Paranoid Personality Disorder 268
Schizoid Personality Disorder 268
Schizotypal Personality Disorder 269
Cluster B: The Dramatic, Emotional, or 270
Erratic Cluster
Borderline Personality Disorder 271
Histrionic Personality Disorder 273
Narcissistic Personality Disorder 274
Antisocial Personality Disorder 275
Cluster C: The Anxious or Fearful Cluster 276
Avoidant Personality Disorder 277
Dependent Personality Disorder 277
Obsessive-Compulsive Personality 279
Disorder
Course of Illness 279
Odd or Eccentric Cluster 280
Dramatic, Emotional, or Erratic Cluster 281
Histrionic Personality Disorder 281
Borderline Personality Disorder 281
Narcissistic Personality Disorder 282
Antisocial Personality Disorder 282
Anxious or Fearful Cluster 282
Avoidant Personality Disorder 282
Dependent Personality Disorder 283
Obsessive-Compulsive Personality 283
Disorder
The Interview 283
Differential Diagnosis 292
Distinguishing between Personality 292
Pathology and an Axis I Disorder
Distinguishing between Personality 292
Pathology and Physiologic
Manifestations of a General Medical
Condition
Evaluating the Patient with Axis I 293
Pathology and Comorbid Personality
Pathology
Evaluating the Patient for Comorbid 293
Personality Disorders
Medical Evaluation 293
Etiology 294
Neurobiology 294
Environment 295
Treatment 295
Psychodynamic Psychotherapy 296
Cognitive Behavior Therapy 296
Supportive Psychotherapy 297
Group Psychotherapy 297
Pharmacotherapy 297
9. EATING DISORDERS 300
Michael J. Devlin and Joanna E. Steinglass
Diagnostic and Clinical Features 300
Core Shared Features 300
Anorexia Nervosa 301
Bulimia Nervosa 302
Binge-eating Disorder 306
Eating Disorder Not Otherwise Specified 307
Epidemiology and Course of Illness 307
Incidence and Prevalence 308
Age of Onset 308
Morbidity and Mortality 309
Long-term Course of Illness 310
Anorexia Nervosa 310
Bulimia Nervosa 312
Binge-eating Disorder 313
The Interview 314
Anorexia Nervosa 314
Bulimia Nervosa 315
Differential Diagnosis 317
Anorexia Nervosa 317
Bulimia Nervosa 317
Medical Evaluation 318
Etiology 319
Biological Theories 320
Genetic Factors 320
Neurotransmitters and Neuropeptides 321
Neuroendocrine Factors 321
Gastrointestinal Factors 322
Psychosocial Theories 322
Cognitive Model 322
Behavioral Model 322
Interpersonal Perspective 323
Cultural Factors 323
Anorexia Nervosa 323
Bulimia Nervosa 325
Treatment 325
Anorexia Nervosa 325
Behavior Treatment 325
Psychotherapy 326
Pharmacotherapy 327
Bulimia Nervosa 327
Psychotherapy 327
Pharmacotherapy 328
Binge-eating Disorder 329
10. SOMATOFORM AND FACTITIOUS DISORDERS 331
Kelli Jane K. Harding and Steven E. Hyler
Diagnostic and Clinical Features 331
Somatoform Disorders 331
Somatic/Sensory Subtype 333
Dissociative Subtype 336
Obsessional/Cognitive Subtype 337
Factitious Disorder 339
Factitious Disorder with Predominantly 341
Physical Signs and Symptoms
Factitious Disorder with Predominantly 342
Psychological Signs and Symptoms
Variants of Factitious Disorder 344
Course of Illness 344
Somatoform Disorders 344
Factious Disorders 347
The Interview 347
Somatoform Disorders 347
Factitious Disorder 348
Differential Diagnosis 350
Somatoform Disorders 350
Factitious Disorder 351
Medical Evaluation 351
Somatoform Disorders 351
Factitious Disorders 352
Etiology 352
Somatoform Disorders 352
Somatization and Pain Disorders 352
Conversion Disorder 353
Hypochondriasis 354
Body Dysmorphic Disorder 354
Factitious Disorder 354
Treatment 355
Somatoform Disorders 355
Somatization and Pain Disorders 355
Conversion Disorder 356
Hypochondriasis 356
Body Dysmorphic Disorder 357
Factitious Disorder 357
11. SUICIDE AND VIOLENCE 360
Cheryl A. Chessick and Robert E. Feinstein
Clinical Features 360
Suicide 360
Violence 361
The Interview 362
Safety 362
Calm Phase 363
Psychomotor Agitation Phase 363
Verbal Aggressive Phase 363
Physical Aggressive Phase 365
Obtaining the History 366
Risk Assessment 367
Current Suicidal and Violent Ideation 367
Past Suicidal and Violent Behavior 369
Treatment History 370
Psychosocial History 371
Family History 371
Physician Reactions 373
Suicidal Patients 373
Violent Patients 374
Differential Diagnosis 374
Suicide 374
Violence 375
Medical Evaluation 376
Etiology 376
Neurobiological Factors 376
Psychosocial Factors 376
Family Influences 376
Societal Influences 377
Treatment 377
Motivation for Treatment 377
Therapeutic Settings 377
Outpatient Treatment 377
Hospitalization 378
Pharmacotherapy 380
Antidepressants 381
Mood-stabilizing Agents 382
Antipsychotics 382
Benzodiazepines 382
Electroconvulsive Therapy 382
Psychotherapy 383
Cognitive Behavior Therapy 383
Psychodynamic Approaches 384
Family Therapy 384
Chronic Suicidality and Violence 385
Legal Issues 385
Commitment 385
Confidentialty 385
The Duty to Warn 386
12. PSYCHOLOGICAL FACTORS AFFECTING MEDICAL 388
CONDITIONS
Lucy A. Epstein and Eve Caligor
Psychological Reactions to Physical Illness 388
General Psychological Responses to 391
Physical Illness
Regression 391
Clinical Features 391
Interview and Management 392
Denial 393
Clinical Features 393
Interview and Management 394
Anxiety 394
Clinical Features 394
Interview and Management 395
Depression 396
Clinical Features 396
Interview and Management 397
Anger and Agitation 398
Clinical Features 398
Interview and Management 400
Individual Personality Traits in Physical 400
Illness
Dependent Personality Traits 401
Clinical Features 401
Interview and Management 401
Controlled Personality Traits 401
Clinical Features 401
Interview and Management 402
Self-dramatizing Personality Traits 402
Clinical Features 402
Interview and Management 403
Long-suffering Personality Traits 403
Clinical Features 403
Interview and Management 403
Suspicious Personality Traits 404
Clinical Features 404
Interview and Management 404
Superior Personality Traits 404
Clinical Features 404
Interview and Management 404
Aloof Personality Traits 405
Clinical Features 405
Interview and Management 405
Psychological Factors Affecting Adherence 405
Clinical Features 405
Interview and Management 406
Psychosocial Stress Affecting a Medical 407
Condition
Clinical Features 407
Interview 408
Management 410
Psychological Aspects of Chronic Illness 411
Clinical Features 411
Interview 414
Management 415
Psychological Aspects of Chronic Pain 416
Clinical Features 416
Interview 418
Management 420
13. CHILD, ADOLESCENT, AND ADULT DEVELOPMENT 424
Jonathan A. Slater, Katharine A Stratigos,
and Janis L. Cutler
Normal and Abnormal Life Development 424
Approach to the Study of Development 424
Patterns of Development 424
Effects of Stress and Trauma on 426
Development
Psychodynamic Theory 426
Infancy: Birth to 12 Months of Age 427
Developmental Progression 427
Affect Regulation 427
Attachment 427
Object Permanence 429
Stranger Anxiety 432
Developmental Vulnerabilities 433
Physical Illness and Caretaking 433
Relationships
Psychopathology 434
Developmental Disorders 434
Parental Psychopathology 434
The Toddler: One to Three Years of Age 434
Developmental Progression 434
Emergence of Autonomy 435
Ambivalence 435
The Acquisition of Symbolic Thought 436
Internal Representations 436
Establishment of Gender Identity 437
Developmental Vulnerabilities 438
Transient Symptoms 438
Psychopathology 439
The Preschool Child: Three to Six Years of 439
Age
Developmental Progression 439
The Autonomous Self and the Emergence 439
of Morality
Imaginative Play 440
The Evolution of Magical Thinking 441
Sexuality 442
Developmental Vulnerabilities 443
The School-age Child: Six to Eleven Years 443
of Age
Developmental Progression 443
Acquiring Competence 444
Evolving Coping Styles and Morality 444
Reading, Writing, and Arithmetic 445
Gender Differentiation 445
Sexual Curiosity and Modesty 445
Developmental Vulnerabilities 447
Psychopathology 447
Adolescence 448
Developmental Progression 448
Achieving Independence Through Groups 448
Consolidation of Identity and Growing 448
Emotional Maturity
Acquisition of Abstract Thought 449
Gender-related Issues 450
Sexuality 451
Risk-taking 451
Developmental Vulnerabilities 453
Psychopathology 453
Adulthood 453
Developmental Progression 453
Gratification in Work and Love 453
Emotional Maturity 455
Cognitive Awareness 455
Sexual Function and Dysfunction 456
Developmental Vulnerabilities 456
Psychopathology 457
Old Age 457
Developmental Progression 457
Changing Relationships 457
Gradual Decline 459
Sexuality in the Elderly 459
Developmental Vulnerabilities 459
Psychopathology 460
14. CHILD AND ADOLESCENT PSYCHIATRY 462
Daniel T. Chrzanowski, Elisabeth B. Guthrie,
Matthew B. Perkins, and Moira A. Rynn
Psychiatric Assessment of Children and 462
Adolescents
The Interview 462
Children 464
Interview with Parents 464
Interview with Child 466
Parents and Child 468
Adolescents 468
Mental Status Examination 469
Rating Scales 470
Medical Evaluation 470
Baseline Laboratory Testing 471
Special Laboratory Testing 472
Psychological Assessment 473
Anxiety Disorders 473
Diagnostic and Clinical Features 473
Separation Anxiety Disorder 475
Generalized Anxiety Disorder 476
Obsessive-Compulsive Disorder 476
Social Phobia (Social Anxiety Disorder) 476
Panic Disorder 476
Specific Phobia 477
Posttraumatic Stress Disorder 477
Differential Diagnosis 477
Treatment and Prognosis 477
Somatoform Disorders 478
Diagnostic and Clinical Features 478
Pain Disorder 478
Conversion Disorder 478
Body Dysmorphic Disorder 478
Hypochondriasis 478
Somatization Disorder 478
Undifferentiated Somatofonn Disorder 479
Differential Diagnosis 479
Etiology 479
Treatment and Prognosis 480
Mood Disorders 480
Diagnostic and Clinical Features 480
Major Depressive Disorder 480
Bipolar Disorder 481
Differential Diagnosis 481
Treatment and Prognosis 482
Depressive Disorders 482
Bipolar Disorder 482
Disruptive Behavior Disorders 483
Diagnostic and Clinical Features 483
Attention Deficit Hyperactivity Disorder 483
Oppositional Defiant Disorder 485
Conduct Disorder 486
Differential Diagnosis 487
Etiology 487
Attention Deficit Hyperactivity Disorder 487
Oppositional Defiant Disorder 488
Conduct Disorder 488
Treatment and Prognosis 488
Attention Deficit Hyperactivity Disorder 488
Oppositional Defiant Disorder 488
Conduct Disorder 489
Learning, Motor Skills, and Communication 489
Disorders
Diagnostic and Clinical Features 489
Reading Disorder 490
Disorder of Written Expression 490
Mathematics Disorder 490
Developmental Coordination Disorder 490
Communication Disorders 491
Expressive Language Disorder 491
Mixed Receptive-expressive Language 491
Disorder
Phonological Disorder 491
Stuttering 491
Etiology and Treatment 492
Reading Disorder 492
Disorder of Written Expression 492
Mathematics Disorder 493
Developmental Coordination Disorder 493
Communication Disorders 493
Stuttering 493
Mental Retardation 493
Diagnostic and Clinical Features 493
Differential Diagnosis 494
Etiology 494
Treatment and Prognosis 494
Pervasive Developmental Disorders 496
Diagnostic and Clinical Features 496
Autistic Disorder 496
Asperger Disorder 497
Rett Disorder 497
Childhood Disintegrative Disorder 498
Differential Diagnosis 498
Etiology 498
Treatment and Prognosis 499
Schizophrenia 499
Diagnostic and Clinical Features 499
Differential Diagnosis 500
Etiology 501
Treatment and Prognosis 501
Tic Disorders 502
Diagnostic and Clinical Features 502
Transient Tic Disorder 502
Chronic Tic Disorder 502
Tourette Disorder 502
Differential Diagnosis 502
Etiology 503
Treatment and Prognosis 503
Eating and Feeding Disorders of Childhood 503
Diagnostic and Clinical Features 504
Pica 504
Rumination Disorder 504
Feeding Disorder of Infancy or Early 504
Childhood
Differential Diagnosis 504
Pica 504
Rumination Disorder 505
Feeding Disorder of Infancy or Early 505
Childhood
Etiology, Treatment, and Prognosis 505
Pica 505
Rumination Disorder 505
Feeding Disorder of Infancy or Early 506
Childhood
Elimination Disorders 506
Diagnostic and Clinical Features 506
Enuresis 506
Encopresis 507
Differential Diagnosis 507
Enuresis 507
Encopresis 507
Etiology, Treatment, and Prognosis 507
Enuresis 507
Encopresis 508
Personality Disorders 509
Diagnostic and Clinical Features 509
Differential Diagnosis 509
Etiology, Treatment, and Prognosis 509
Psychosocial Treatments 509
Working with Parents 509
Cognitive Behavior Therapy 510
Interpersonal Therapy 511
Psychodynamic Psychotherapy 512
Pharmacotherapy 512
Selective Serotonin Reuptake Inhibitors 512
Serotonin Norepinephrine Reuptake 513
Inhibitors
Bupropion 513
Tricyclic Antidepressants 513
Stimulants 513
Antipsychotics 514
Mood Stabilizers 514
Benzodiazepines 514
15. PSYCHOTHERAPY 517
David D. Olds and Fredric N. Busch
The Therapeutic Process 517
Beginning Phase 517
Middle Phase 523
End Phase 523
Basic Characteristics of Psychotherapies 524
Transference 524
Countertransference 524
Corrective Emotional Experience 524
Emotional Intensity 525
Resistance 525
Psychoanalytic Psychotherapies 525
Brief Dynamic Psychotherapy 526
Indications and Selection Criteria 526
Therapeutic Process 531
Psychoanalysis 532
Indications and Selection Criteria 532
Therapeutic Process 534
Free Association 534
Therapeutic Neutrally 534
Clarification 534
Interpretation 535
Defense Analysis 535
Resistance 535
Dream Analysis 536
Transference Neurosis 536
Modifications 536
Working Through 537
Intersubjectivity 537
Long-term Psychoanalytic Psychotherapy 537
Indications and Selection Criteria 538
Therapeutic Process 538
Transference Focused Psychotherapy 541
Indications and Selection Criteria 542
Therapeutic Process 542
Panic-focused Psychodynamic Psychotherapy 544
Therapeutic Process 544
Cognitive-Behavioral Therapies 545
Behavior Therapy 545
Indications and Selection Criteria 547
Therapeutic Process 548
Cognitive Behavior Therapy 549
Indications and Selection Criteria 549
Therapeutic Process 549
Dialectical Behavior Therapy 551
Indications and Selection Criteria 553
Therapeutic Process 553
Group Therapy 553
Individual Therapy 553
Telephone Consultation 554
Consultation Team 555
The Multiple-person Therapies 555
Interpersonal Psychotherapy 555
Indications and Selection Criteria 555
Therapeutic Process 555
Family Therapy 557
Systems Approach 557
Psychodynamic Approach 558
Group Therapy 561
Supportive Psychotherapies 563
Crisis Intervention 564
Indications and Selection Criteria 564
Therapeutic Process 564
Medical Illness 564
Ego Deficits 565
Indications and Selection Criteria 565
Therapeutic Process 566
16. PHARMACOTHERAPY AND ELECTROCONVULSIVE 568
THERAPY
Jonathan W. Stewart, L. Mark Russakoff, and
Jessica Ann Stewart
General Principles 568
Antipsychotic Agents 571
Indications and Contraindications 574
Pretreatment Evaluation 576
Initiating Treatment 576
Combination Therapy 577
Dosing 577
Long-acting Injectable Antipsychotics 577
Side Effects 578
Weight Effects 578
Extrapyramidal Symptoms 578
Tardive Dyskinesia 579
Sedation 580
Anticholinergic Effects 580
Hypotension 580
Sexual Effects 580
Hepatic Effects 581
Dermatologic Effects 581
Hematological Effects 581
Seizure Effects 581
Ophthalmologic Effects 582
Neuroleptic Malignant Syndrome 582
Drug Interactions 582
Medication Choice 582
Antiparkinsonian Agents 583
Antidepressant Agents 583
Indications 584
Dosing Strategies 585
Selective Serotonin Reuptake Inhibitors 586
Dosing 586
Side Effects 587
Drug Interactions 588
Tricyclic Antidepressants 589
Dosing 589
Side Effects 591
Other Newer Antidepressants 591
Dosing and Side Effects 593
Monoamine Oxidase Inhibitors 594
Dosing 595
Side Effects 595
Tyramine-free Diet 596
Drug Interactions 596
Assessment of Treatment Response 596
Placebo Effects 597
Switch Strategies 597
Augmentation Strategies 597
Discontinuing an Antidepressant 598
Mood Stabilizers 598
Lithium 598
Pretreatment Evaluation 598
Dosing 599
Side Effects 600
Anticonvulsants 600
Pretreatment Evaluation 601
Dosing 601
Side Effects 601
Anxiolytic Medications and Hypnotic Agents 602
Benzodiazepines 602
Pretreatment Evaluation 602
Drug Selection 606
Dosing 606
Side Effects 606
Non-benzodiazepine Anxiolytics and 608
Hypnotics
Substance Abuse Agents 608
Electroconvulsive Therapy 610
Indications and Contraindications 610
Pretreatment Evaluation 611
Treatment 611
Side Effects 611
INDEX 613
|
|
Your cart is empty.
| WEEKLY BESTSELLERS Under same category |
|
Know Your Mind : Everyday Emotional and Psychological Problems and How to Overcome Them -- Paperback
Freeman, Daniel/ Freeman, Jason
|
|
|
Hakim, Catherine
|
|
|
Furnham, Adrian
|
|
|
Smith, Shawn T.
|
|
|
Hefferon, Kate/ Boniwell, Ilona
|
|




